Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
Clinical trial NCT00510471 · TERMINATED
Trial details
- NCT number
- NCT00510471
- Sponsor
- Genitope Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.